PD1 Resistance with a Multi-Omic Approach
PharmaTalkRadio10 Mar 2020

PD1 Resistance with a Multi-Omic Approach

Anti-PD-1 therapy has transformed cancer care but most patients do not respond. It is increasingly clear that there will be no single biomarker of response to a PD-1, and that a multi-omic approach will be required. In this podcast, first recorded at the 4th annual IO Combinations 360° conference, Dr Danny Wells, Parker Institute for Cancer Immunotherapy will address: Orthogonality and correlation of response biomarkers across histologiesIntegration of multi-omic data sets for mechanistic insights into tumor immunobiologyThe translational approaches to PD1 resistance program at the Parker Institute To learn more about the upcoming IO Combinations 360° conference please visit, www.iocombinations360.com

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(461)

Populært innen Vitenskap

fastlegen
tingenes-tilstand
romkapsel
rss-nysgjerrige-norge
sinnsyn
forskningno
rekommandert
dekodet-2
liberal-halvtime
rss-paradigmepodden
fjellsportpodden
rss-rekommandert
tidlose-historier
jss
grunnstoffene
villmarksliv
hva-er-greia-med
vett-og-vitenskap-med-gaute-einevoll
nordnorsk-historie
aldring-og-helse-podden